Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease

[1]  A. Hofman,et al.  Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. , 1997, Circulation.

[2]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[3]  G. Lowe,et al.  Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease , 1996, British journal of haematology.

[4]  G. Lowe,et al.  The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. , 1995, European heart journal.

[5]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[6]  J. Cooper,et al.  Factor VIII, ABO blood group and the incidence of ischaemic heart disease , 1994, British journal of haematology.

[7]  B. Margetts,et al.  Interactions between people's diet and their smoking habits: the dietary and nutritional survey of British adults. , 1993, BMJ.

[8]  J. Jansson,et al.  Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up , 1993, Circulation.

[9]  P. Donnan,et al.  Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. , 1993, Atherosclerosis.

[10]  A. Rumley,et al.  Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease , 1993, The Lancet.

[11]  P. Ridker,et al.  Endogenous tissue-type plasminogen activator and risk of myocardial infarction , 1993, The Lancet.

[12]  P. Donnan,et al.  Blood Viscosity, Fibrinogen, and Activation of Coagulation and Leukocytes in Peripheral Arterial Disease and the Normal Population in the Edinburgh Artery Study , 1993, Circulation.

[13]  J. Baron,et al.  Do cigarette smokers have diets that increase their risks of coronary heart disease and cancer? , 1993, American journal of epidemiology.

[14]  G. Reaven,et al.  Insulin resistance and cigarette smoking , 1992, The Lancet.

[15]  G. Lowe.  Blood Viscosity and Cardiovascular Disease , 1992, Thrombosis and Haemostasis.

[16]  R. Prescott,et al.  Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. , 1992, American journal of epidemiology.

[17]  E. Rimm,et al.  Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.

[18]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[19]  H Tunstall-Pedoe,et al.  Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers , 1991, British Journal of Nutrition.

[20]  W. Krupski.  The peripheral vascular consequences of smoking , 1991, Annals of vascular surgery.

[21]  J. Haddow,et al.  Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. , 1989, BMJ.

[22]  E. Kruithof,et al.  Fibrinolysis in Normal Subjects - Comparison Between Plasminogen Activator Inhibitor and Other Components of the Fibrinolytic System , 1988, Thrombosis and Haemostasis.

[23]  T. Meade,et al.  EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE , 1987, The Lancet.

[24]  M. Criqui,et al.  Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. , 1987, American journal of epidemiology.

[25]  E. Ernst,et al.  Dose—effect relationship between smoking and blood rheology , 1987, British journal of haematology.

[26]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[27]  E Jucha,et al.  Blood pressure in smokers and nonsmokers: epidemiologic findings. , 1986, American heart journal.

[28]  J. Yarnell,et al.  Diet, smoking, social class, and body mass index in the Caerphilly Heart Disease Study. , 1984, The American journal of clinical nutrition.

[29]  R J Prineas,et al.  International diagnostic criteria for acute myocardial infarction and acute stroke. , 1984, American heart journal.

[30]  J. Yarnell,et al.  A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. , 1983, Human nutrition. Applied nutrition.

[31]  B. Nemery,et al.  Smoking, lung function, and body weight. , 1983, British medical journal.

[32]  D. Ballantyne,et al.  High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. , 1982, Metabolism: clinical and experimental.

[33]  R. Cummins,et al.  Smoking and drinking by middle-aged British men: effects of social class and town of residence. , 1981, British medical journal.

[34]  B. Lewis,et al.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.

[35]  D. Jacobs,et al.  Smoking and weight: the Minnesota Lipid Research Clinic. , 1981, American journal of public health.

[36]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[37]  J. Mann,et al.  Intermittent claudication: prevalence and risk factors. , 1978, British medical journal.

[38]  S. Punsar,et al.  Smoking, carbon monoxide, and atherosclerotic diseases. , 1978, British medical journal.

[39]  W. Kannel,et al.  Changes associated with quitting cigarette smoking: the Framingham Study. , 1975, American heart journal.

[40]  C. Seltzer.  Effect of smoking on blood pressure. , 1974, American heart journal.

[41]  M. Collen,et al.  Smoking habits and the leukocyte count. , 1973, Archives of environmental health.

[42]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[43]  C. Lowe,et al.  Obesity and Smoking Habits , 1971, British medical journal.

[44]  J. Lellouch,et al.  Smoking and leucocyte-counts. Results of an epidemiological survey. , 1971, Lancet.

[45]  D. Ogston,et al.  The influence of cigarette smoking on the plasma fibrinogen concentration. , 1970, Atherosclerosis.

[46]  M. Woodward,et al.  An iterative technique for identifying smoking deceivers with application to the Scottish Heart Health Study. , 1992, Preventive medicine.

[47]  A. Blann.  Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides , 1991 .

[48]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .